Kamada KMDA
NASDAQ KMDA
$8.20 +0.00 (+0.00%)
As of: Oct 2, 2026 · 11:33 AM EDT

Kamada (KMDA) Return on Assets [ROA] (2018 - 2026)

Updated

Kamada (KMDA) posted Return on Assets [ROA] of 5.81% for the quarter ended Jun 30, 2026, up 0.69 percentage points from 5.12% a year earlier and up 0.46 percentage points from the prior quarter.

Analysis

Kamada (KMDA) Return on Assets [ROA] (2018 - 2026) Analysis & Trends

For the year ended Dec 31, 2025, Kamada's Return on Assets [ROA] came in at 5.38%, up 1.40 percentage points from the prior year.

  • Annual Return on Assets [ROA] has increased for four consecutive years, though with a five-year change of -3.54 percentage points (years ended Dec 2020 to Dec 2025).
  • In prior years, Kamada's Return on Assets [ROA] was 3.98% in the year ended Dec 31, 2024 (+1.53 pp), 2.45% in the year ended Dec 31, 2023 (+3.17 pp), -0.72% in the year ended Dec 31, 2022 (+0.12 pp) and -0.84% in the year ended Dec 31, 2021 (-9.76 pp).
  • The figure for the quarter ended Jun 30, 2026 stands as the highest quarterly Return on Assets [ROA] since the quarter ended Mar 31, 2021.
  • On a year-over-year basis, Return on Assets [ROA] has increased in each of the last 15 quarters, with an average year-over-year change of +1.22 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was the quarter ended Sep 30, 2023, with a gain of 5.19 percentage points; the weakest was the quarter ended Jun 30, 2022, with a drop of 9.49 percentage points.
  • According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 5.35% (quarter ended Mar 31, 2026), 5.34% (quarter ended Dec 31, 2025) and 5.49% (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Kamada 488.02 Mn 197.08 Mn 22.47 Mn 5.81%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.81%
Mar 31, 2026 5.35%
Dec 31, 2025 5.34%
Sep 30, 2025 5.49%
Jun 30, 2025 5.12%
Mar 31, 2025 4.30%
Dec 31, 2024 4.00%
Sep 30, 2024 4.47%
Jun 30, 2024 4.34%
Mar 31, 2024 3.57%
Dec 31, 2023 2.39%
Sep 30, 2023 1.89%
Jun 30, 2023 1.09%
Mar 31, 2023 -0.72%
Dec 31, 2022 -0.72%
Sep 30, 2022 -3.29%
Jun 30, 2022 -3.82%
Mar 31, 2022 -2.17%
Dec 31, 2021 -0.83%
Sep 30, 2021 2.04%
API Access

Kamada Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=KMDA&period=max&api_key=YOUR_API_KEY